Form 4: Amarin Director Bonfiglio Receives Stock Options and Restricted Stock Units

Director Patrice Eadon Bonfiglio acquired stock options and restricted stock units (RSUs) following Amarin's annual general meeting.

Summary

• On April 18, 2024, Patrice Eadon Bonfiglio, a director of Amarin Corp PLC, was granted stock options and restricted stock units (RSUs).
• The stock options grant is for 179,795 ordinary shares at an exercise price of $0.87.
• These options vest over three years, with 33% vesting on the first anniversary and the remainder in equal quarterly installments.
• Bonfiglio also received 50,287 RSUs, which vest in three equal annual installments starting April 18, 2025.
• Each RSU represents the right to receive one ordinary share or cash at Amarin's discretion.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate governance practice of incentivizing directors with equity, which is generally viewed positively. There are no indications of negative performance or concerns.

Positives

• The grant of stock options and RSUs aligns the director's interests with those of the shareholders.
• Vesting schedules encourage long-term commitment and performance.

Industry Context

Grants of stock options and RSUs are common practices for incentivizing and retaining key personnel in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation practices in the pharmaceutical industry.
• Companies like Pfizer, Amgen, and Novartis also use similar equity-based compensation to align executive and director interests with shareholder value.
• The vesting schedules are also typical, encouraging long-term commitment.

Stakeholder Impact

• The grants aim to align the director's interests with those of shareholders, potentially leading to better corporate governance and performance.
• Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates